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Abstract
 
The mechanism by which T cell receptor specificity determines the outcome of the CD4/CD8
lineage decision in the thymus is not known. An important clue is the fact that major histocom-
patibility complex (MHC)-I–signaled thymocytes paradoxically appear as CD4
 
 
 
8
 
lo 
 
transitional
cells during their differentiation into CD8
 
  
 
T cells. Lineage commitment is generally thought
to occur at the CD4
 
 
 
8
 
  
 
(double positive) stage of differentiation and to result in silencing of
the opposite coreceptor gene. From this perspective, the appearance of MHC-I–signaled thy-
mocytes as CD4
 
 
 
8
 
lo 
 
cells would be due to effects on CD8 surface protein expression, not CD8
gene expression. But contrary to this perspective, this study demonstrates that MHC-I–signaled
thymocytes appear as CD4
 
 
 
8
 
lo 
 
cells because of transient down-regulation of CD8 gene ex-
pression, not because of changes in CD8 surface protein expression or distribution. This study
also demonstrates that initial cessation of CD8 gene expression in MHC-I–signaled thymocytes
is not necessarily indicative of commitment to the CD4
 
  
 
T cell lineage, as such thymocytes re-
tain the potential to differentiate into CD8
 
  
 
T cells. These results challenge classical concepts of
lineage commitment but fulfill predictions of the kinetic signaling model.
Key words: lineage commitment • kinetic signaling • coreceptor reversal • positive selection
 
Introduction
 
Immature CD4
 
 
 
8
 
  
 
(double positive [DP]
 
*
 
) thymocytes are
signaled in the thymus to differentiate into mature single
positive T cells by TCR engagement of intrathymic
MHC–peptide complexes (1). TCR engagement of in-
trathymic peptide–MHC-II complexes results in differenti-
ation of DP thymocytes into mature CD4
 
  
 
T cells whereas
TCR engagement of intrathymic peptide–MHC-I com-
plexes results in differentiation of DP thymocytes into
mature CD8
 
  
 
T cells (2, 3). The mechanism by which the
MHC class specificity of surface TCR complexes deter-
mines lineage choice remains an unresolved problem in
developmental immunology. It is thought that lineage
choice is a consequence of the coreceptor molecules that
individual TCRs use to engage intrathymic ligands, as
TCR engagement of peptide–MHC-II complexes generally
requires coengagement of surface CD4 coreceptor molecules
whereas TCR engagement of peptide–MHC-I complexes
generally requires coengagement of surface CD8 corecep-
tor molecules (4, 5). However, the actual mechanism by
which TCR and coreceptor coengagements influence lin-
eage choice remains a matter of intense controversy.
Classical models of lineage commitment are of two gen-
eral types: instructional and stochastic (6–10). Instructional
models of lineage commitment propose that TCR plus
CD4 coengagements on DP thymocytes terminate CD8
gene expression and dictate commitment to the CD4
 
  
 
T
cell lineage by transducing signals that differ either qualita-
tively or quantitatively (in strength or duration) from sig-
nals transduced by TCR plus CD8 coengagements that
terminate CD4 gene expression and dictate commitment to
the CD8
 
  
 
T cell lineage (11–15). Stochastic models of lin-
eage commitment propose that coengagement of TCR
with either coreceptor molecule signals DP thymocytes to
randomly terminate expression of one coreceptor gene,
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*
 
Abbreviations used in this paper:
 
 DP, double positive; hCD2, human CD2.T
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Basis for Reduced CD8 Expression on MHC-I–signaled Thymocytes
 
with only thymocytes still expressing matching TCR and
coreceptor molecules responsive to subsequent survival sig-
nals (16, 17). In both models, lineage commitment is pos-
tulated to occur in DP thymocytes and result in silencing of
the opposite coreceptor gene.
As a result, classical models of lineage commitment pre-
dict that DP thymocytes that have committed to the CD4
 
 
 
T cell lineage have terminated CD8 gene expression and
therefore will lose CD8 surface protein expression and ap-
pear as CD4
 
 
 
8
 
lo 
 
transitional cells. Reciprocally, signaled
DP thymocytes that have committed to the CD8
 
  
 
T cell
lineage have terminated CD4 gene expression and will lose
CD4 surface protein expression and appear as CD4
 
lo
 
8
 
 
 
cells. However, experimental observations are discordant
with these predictions as assessment of CD4
 
 
 
8
 
lo 
 
and
CD4
 
lo
 
8
 
  
 
transitional populations revealed that a significant
proportion of CD8 lineage cells initially appear as CD4
 
 
 
8
 
lo
 
transitional cells (18–22). The appearance of CD8-commit-
ted thymocytes as CD4
 
 
 
8
 
lo 
 
transitional cells is paradoxical
on two levels, as: (a) CD8-committed thymocytes are
thought to have terminated CD4 gene expression, yet these
cells display high levels of CD4 proteins on their cell sur-
face, and (b) CD8-committed thymocytes are thought to
express CD8 coreceptor genes, yet these cells display low
levels of CD8 proteins on their cell surface. Although the
paradoxical loss of CD8 surface proteins on MHC-I–sig-
naled thymocytes had not been predicted, it could be rec-
onciled with classical lineage commitment models by hy-
pothesizing that it was due to a direct effect of MHC-I
signals on CD8 surface proteins that resulted in reduced
CD8 expression on CD8-committed thymocytes (9, 22,
23). This classical view of CD8
 
  
 
T cell differentiation is de-
picted in Fig. 1 A.
In contrast, the kinetic signaling model of lineage com-
mitment proposes that signaled DP thymocytes terminate
CD8 gene expression and transcriptionally convert into
CD4
 
 
 
8
 
  
 
intermediate thymocytes that still retain the po-
tential to differentiate into either CD4
 
  
 
or CD8
 
  
 
T cells
(24–26). So kinetic signaling postulates that lineage com-
mitment occurs after DP thymocytes have converted into
CD4
 
 
 
8
 
  
 
intermediate thymocytes. According to the ki-
netic signaling model, lineage direction is determined in
CD4
 
 
 
8
 
  
 
intermediate thymocytes simply by whether
TCR-mediated positive selection signals persist or cease. If
TCR signaling persists, intermediate CD4
 
 
 
8
 
  
 
thymocytes
differentiate into CD4
 
  
 
T cells, but if TCR signaling
ceases, intermediate CD4
 
 
 
8
 
  
 
thymocytes differentiate into
CD8
 
  
 
T cells. As a result, a critical step in the differentia-
tion of intermediate CD4
 
 
 
8
 
  
 
thymocytes into CD8
 
  
 
T
cells is the silencing of CD4 and reinitiation of CD8 gene
expression, referred to as “coreceptor reversal.” Conse-
quently, the kinetic signaling model predicts that MHC-I–
signaled thymocytes initially appear as CD4
 
 
 
8
 
lo 
 
cells be-
cause they initially terminate CD8 gene expression before
undergoing coreceptor reversal to transcriptionally become
CD4
 
 
 
8
 
  
 
thymocytes. The kinetic signaling view of CD8
 
 
 
T cell differentiation in the thymus is depicted in Fig. 1 B.
Determining the basis for reduced CD8 surface protein
 
expression on MHC-I–signaled thymocytes during CD8
 
  
 
T
cell differentiation tests predictions made by different con-
cepts of how lineage commitment occurs. The classical con-
cept that lineage commitment occurs in DP thymocytes and
results in irreversible silencing of the opposite coreceptor
gene predicts that low CD8 surface protein expression on
MHC-I–signaled CD4
 
 
 
8
 
lo 
 
thymocytes is due to direct ef-
fects on CD8 surface protein expression, not CD8 gene ex-
pression. In contrast, the kinetic signaling model predicts
that low CD8 surface protein expression on MHC-I–sig-
naled CD4
 
 
 
8
 
lo 
 
thymocytes is due to down-regulation of
CD8 gene expression. Consequently, this study has at-
tempted to determine the actual basis for reduced CD8 sur-
face protein expression on MHC-I–signaled CD4
 
 
 
8
 
lo 
 
thy-
mocytes. These results demonstrate that reduced CD8
surface expression on MHC-I–signaled CD4
 
 
 
8
 
lo 
 
thymocytes
is not due to internalization nor slow reexpression of CD8
surface proteins, but is due to down-regulated CD8 gene
expression. In addition, this study demonstrates that down-
regulation of CD8 gene expression does not imply commit-
ment to the CD4 lineage, as many intermediate CD4
 
 
 
8
 
 
 
thymocytes retain the ability to differentiate into CD8
 
  
 
T
cells. These results support the kinetic signaling model but
challenge more classical concepts of lineage commitment.
 
Materials and Methods
 
Animals.
 
Mice deficient in MHC-II (MHC-II
 
o
 
; reference
27), CD8
 
  
 
(CD8
 
 
 
o
 
; reference 5), or CD8
 
  
 
(CD8
 
 
 
o
 
; reference
28) were used at 8–12 wk of age and maintained in our own ani-
mal facility. MHC-II
 
o 
 
mice were bred with CD8
 
 
 
o 
 
mice to gen-
erate II
 
 
 
CD8
 
 
 
o 
 
mice, and were bred with CD8
 
 
 
o 
 
mice to gener-
ate II
 
 
 
CD8
 
 
 
o 
 
mice. 
CD8
 
  
 
transgenic mice constructed with human CD2 (hCD2)-
based CD8
 
  
 
transgenes encoding either full-length CD8
 
  
 
or tail-
less CD8
 
   
 
molecules have been described (29, 30). Transgenic
and endogenous CD8
 
  
 
proteins expressed different allelic forms
of CD8
 
  
 
with transgenic CD8
 
  
 
proteins being CD8
 
 
 
.1 and en-
dogenous CD8
 
 
 
 proteins being CD8
 
 
 
.2. The CD8
 
  
 
transgenic
mouse lines expressed transgenic and endogenous CD8
 
  
 
proteins
at comparable levels. The CD8
 
 
 
.1 transgene was introduced by
mating into MHC-II
 
o
 
, II
 
o
 
CD8
 
 
 
o
 
, and II
 
o
 
CD8
 
 
 
  
 
mice to generate
MHC-II
 
o 
 
mice that either expressed both endogenous and
transgenic CD8
 
  
 
proteins or expressed only transgenic CD8
 
 
 
proteins.
Line 30 transgenic mice expressing a transgene encoding
hCD2 cDNA under the control of the CD4 locus control region
(including the CD4 silencer element) were provided by D. Litt-
man (Skirball Institute of Biomolecular Medicine, New York,
NY; 31). Surface expression of hCD2 protein on thymocytes and
T cells in Line 30 mice serves as a faithful reporter of CD4 pro-
moter activity and strictly parallels CD4 gene expression (31).
Line 30 mice were mated with MHC-II
 
o 
 
mice to generate
MHC-II
 
o 
 
Line 30 mice.
 
Antibodies and Reagents.
 
Fluorochrome-conjugated antibodies
with the following specificities were used for direct immuno-
fluorescence: pan CD8
 
  
 
(53-6.7; BD Biosciences), CD8
 
 
 
.1 (116-
113.1; reference 32), CD8
 
 
 
.2 (2.43; reference 33), CD4 (GK1.5;
BD Biosciences), TCR
 
  
 
(H57-597; BD Biosciences), and hCD2
(G11; Caltag). Recombinant murine IL-7 (R&D Systems) was
added to cultures where indicated.T
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Flow Cytometry and Electronic Cell Sorting. Cells were har-
vested, stained with fluorochrome-conjugated antibodies, and
analyzed on a multi-laser FACSVantage™ SE (Becton Dickin-
son). Dead cells were excluded by forward light scatter gating and
propidium iodide staining. Analysis was performed using software
developed at the National Institutes of Health.
Pronase Treatment and the Coreceptor Reexpression Assay. Where
indicated, thymocytes were pronase treated to remove pre-
existing surface CD4 and CD8 proteins (22). 5   106/ml cells
were treated with 0.01% pronase (Calbiochem) for 15 min at
37 C and then cultured at 37 C overnight during which time
they reexpressed the coreceptor molecules they were actively
transcribing (22). For quantitative analysis of surface coreceptor
reexpression, CD4 and CD8 fluorescence on thymocytes at
various times after pronase stripping was quantitated in total
fluorescence units and expressed as a percentage of CD4 and
CD8 fluorescence on DP thymocytes after full coreceptor re-
expression at 24 h, which was set equal to 100% and was com-
parable to CD4 and CD8 fluorescence on untreated DP thy-
mocytes.
In Vitro Suspension Culture. Purified thymocyte subpopula-
tions were placed in suspension cultures as previously described
(24, 26). Where indicated, recombinant murine IL-7 was added
at 6 ng/ml final concentration.
Results
To determine the mechanism by which CD8 surface
protein expression is reduced on MHC-I–signaled thy-
mocytes, we introduced a CD8 .1 transgene into MHC-
IIo mice so that MHC-I–signaled thymocytes would ex-
press two different CD8   molecules, i.e., endogenously
encoded CD8 .2 and transgenically encoded CD8 .1
molecules (29, 30). Endogenously encoded CD8 .2 pro-
teins and transgene-encoded CD8 .1 proteins were ex-
pressed on the cell surface at similar levels and were identi-
cal except for the single amino acid change in the
extracellular domain that is responsible for their allelism.
However, the genes encoding endogenous and transgenic
CD8  proteins were quite different from one another. The
endogenous CD8 .2 gene utilizes CD8 promoter and
CD8 regulatory elements, whereas the CD8 .1 transgene
utilizes heterologous hCD2 promoter/enhancer elements
(34). Thus, if MHC-I signaling initially reduces CD8 sur-
face expression on DP thymocytes by directly affecting
CD8 surface proteins, both endogenous CD8 .2 and trans-
genic CD8 .1 protein levels will be equally reduced as the
two CD8 proteins are essentially identical. However, if
MHC-I signaling initially reduces CD8 surface expression
on DP thymocytes by targeting CD8 regulatory elements
and down-regulating CD8 gene expression, surface expres-
sion of endogenously encoded CD8 .2 proteins will be re-
duced but surface expression of transgenically encoded
CD8 .1 proteins will not be reduced.
Assessment of CD8 Protein Internalization as the Basis for
Reduced CD8 Surface Protein Expression on MHC-I–signaled
Thymocytes. Immature thymocytes that have been stimu-
lated by intrathymic ligands to undergo positive selection
up-regulate TCR surface expression to become TCRhi
cells. Gating on TCRhi cells in MHC-IIo mice and assessing
surface expression of endogenously encoded CD4 and
CD8   molecules revealed two major populations of
MHC-I–signaled thymocytes in both normal and CD8 
transgenic mice: a transitional thymocyte population that is
CD4  CD8 lo  and a mature population that is CD4 
CD8 hi (Fig. 2). Previous studies have documented that
transitional CD4  CD8lo cells are the progeny of MHC-I–
signaled DP thymocytes that then differentiate into CD8 
T cells (20–22). Importantly, it can be seen that surface ex-
pression of endogenous CD8  molecules paralleled that of
surface CD8   molecules on both wild-type and CD8 
transgenic mice, in that endogenous CD8  surface expres-
sion was low on CD8 lo cells and high on CD8 hi cells
(Fig. 2). In sharp contrast, surface expression of transgenic
CD8   molecules on CD8   transgenic thymocytes re-
mained high on both CD8 lo and CD8 hi cells (Fig. 2).
Thus, although intrathymic MHC-I signals in DP thy-
mocytes reduced surface expression of endogenous CD8 
molecules, MHC-I signals did not alter surface expression
of transgenic CD8  molecules on the same cells. Because
endogenous and transgenic CD8  proteins are essentially
identical, these results indicate that intrathymic MHC-I
signals do not reduce CD8  surface protein expression by
inducing CD8  protein internalization.
Figure 1. Alternative schematic representations of the mechanism by
which MHC-I–signaled thymocytes differentiate into CD8  T cells. Dif-
ferentiation of MHC-I–signaled thymocytes is schematized as a two
color plot of surface CD4 versus CD8 expression of MHC-IIo thy-
mocytes. Labels outside the plot identify thymocyte subpopulations by
surface levels of CD4/CD8 protein expression. Labels inside the cells in-
dicate coreceptor gene expression. Arrows indicate proposed precursor/
progeny relationships according to either classical lineage commitment
models (A) or the kinetic signaling model (B). Cells in light gray are ab-
sent in MHC-IIo thymi but present in normal thymi. (A) Classical lineage
commitment models (e.g., instruction, stochastic/selection, strength of
signal, duration of signal) are all based on the central paradigm that lin-
eage commitment occurs in DP thymocytes and results in silencing of
the opposite coreceptor gene. As a result, all classical models require that
MHC-I–signaled thymocytes appear as CD4 8lo transitional cells because
of changes in CD8 protein expression, not CD8 gene expression. (B)
The kinetic signaling model proposes that TCR-signaled DP thymocytes
initially terminate CD8 gene expression and appear as CD4 8lo transi-
tional cells as a result of diminished or absent CD8 gene expression. In
the kinetic signaling model, TCR disengagement of MHC-I ligands oc-
curs in CD4 8lo transitional cells because of diminished surface CD8
coreceptor levels and results in cessation of TCR signaling, reversal of
coreceptor gene expression, and terminal differentiation into CD8  T cells.T
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Although transgenic CD8   molecules are essentially
identical to full-length endogenous CD8  molecules, thy-
mocytes also express a splice variant of endogenous CD8 
(referred to as CD8  ) lacking a cytosolic tail (35). Conse-
quently, we considered the unlikely possibility that in-
trathymic MHC-I signals might have reduced surface
expression of endogenous, but not transgenic, CD8  mol-
ecules on CD8 lo cells by selectively internalizing CD8
complexes containing a CD8   chain. We introduced ei-
ther the full-length CD8  or tailless CD8   transgene into
IIoCD8 o mice that lack endogenous CD8  expression so
that all surface CD8    complexes would contain only
CD8   transgenic molecules (Fig. 3). Gating on TCRhi
cells and assessing surface expression of endogenously en-
coded CD4 and CD8  molecules revealed the same two
major populations of MHC-I–signaled thymocytes in both
CD8   and CD8    transgenic mice: a transitional thy-
mocyte population that was CD4 8 lo and a mature popu-
lation that was CD4 8 hi. Importantly, surface expression
of either full-length or tailless CD8  transgenic molecules
was only slightly reduced on CD8 lo thymocytes relative
to CD8 hi thymocytes (Fig. 3). These results exclude the
unlikely possibility that intrathymic MHC-I signals reduce
surface CD8 protein expression by selectively internalizing
CD8   complexes.
Because surface CD8   heterodimers bind to MHC-I
molecules with greater avidity than do CD8    ho-
modimers (30), it was conceivable that intrathymic MHC-I
engagements might result in selective internalization of
CD8    complexes but not CD8    complexes. Conse-
quently, we considered that intrathymic MHC-I signals
might have failed to reduce surface expression of transgenic
CD8  molecules because transgenic CD8  molecules were
expressed as CD8    homodimers whereas endogenous
CD8  molecules were expressed as CD8   heterodimers.
To assess this possibility, we introduced the CD8  trans-
gene into IIoCD8 o mice so that the only CD8 complexes
thymocytes could express would be CD8    complexes
composed of endogenous and/or transgenic CD8  mole-
cules (Fig. 4). Gating on TCRhi cells and assessing surface
expression of endogenously encoded CD4 and CD8 .2
molecules again revealed two major populations of MHC-
Figure 2. Differential expres-
sion of endogenous and trans-
genic CD8  expression on thy-
mocytes signaled in vivo by
intrathymic MHC-I complexes.
Thymocytes from MHC-II0 mice
(either with or without the
CD8   transgene) were surface
stained for TCR , CD4, CD8 ,
and either CD8 .2 (endogenous
CD8 ) or CD8 .1 (transgenic
CD8 ) expression and analyzed
by four color flow cytometry. Shown on whole thymus populations from each mouse are CD4 versus CD8  and TCR  expression (left panels). Because
intrathymically signaled thymocytes up-regulate surface TCR expression and become TCRhi cells, we gated on TCRhi thymocytes to determine surface
coreceptor expression on in vivo–signaled cells (right panels). CD4 versus CD8  expression on TCRhi thymocytes is shown, with CD8 lo cells identified
by the blue rectangular gate and CD8 hi identified by the red rectangular gate. CD8  staining on CD8 lo (blue line) and CD8 hi (red line) TCRhi thy-
mocytes was compared for surface expression of endogenous CD8 .2 and transgenic CD8 .1 molecules on the identical cells. Surface expression of en-
dogenous CD8 .2 molecules was found to parallel that of CD8 , in that CD8 .2 expression was low on CD8 lo cells and high on CD8 hi TCRhi cells.
In contrast, surface expression of transgenic CD8 .1 molecules did not parallel that of CD8 , in that CD8 .1 expression was identical on CD8 lo and
CD8 hi TCRhi thymocytes.
Figure 3. Effect of intrathymic
MHC-I signals on surface expression
of full-length CD8   and tailless
CD8   transgenic molecules. Thy-
mocytes were obtained from
MHC-IIo mice that expressed only
endogenous CD8 molecules (both
CD8   and CD8  ; top row), or
from MHC-IIo CD8 o mice that ei-
ther expressed only full-length
CD8   (middle row) or tailless
CD8    (bottom row) transgenic
molecules. Thymocytes were sub-
jected to the same four color flow
cytometric analysis as in Fig. 2, with
the exception that both endogenous
and transgenic CD8   molecules
were stained with a pan anti-CD8  mAb. In contrast to endogenous CD8  molecules that were expressed at significantly lower levels on CD8 lo (blue
line) than CD8 hi (red line) TCRhi thymocytes, transgenic CD8  molecules were expressed at similar levels on CD8 lo and CD8 hi TCRhi thymocytes
regardless of whether the transgene encoded full-length CD8  or tailless CD8   molecules.T
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I–signaled thymocytes: a transitional thymocyte population
that was CD4  CD8 .2lo and a mature population that was
CD4  CD8 .2hi (Fig. 4). Even though all surface CD8
complexes on these thymocytes could only be CD8   ho-
modimers, surface expression of endogenous CD8 .2 mol-
ecules was obviously reduced on CD8 .2lo thymocytes,
whereas surface expression of transgenic CD8 .1 mole-
cules was not reduced on the very same CD8 .2lo cells
(Fig. 4). The detection of TCRhi  transitional CD4 
CD8 .2lo thymocytes in IIoCD8 o mice directly excludes
the possibility that intrathymic MHC-I signals fail to re-
duce surface expression of CD8   homodimers.
These results demonstrate that MHC-I–signaled CD4 8lo
thymocytes display reduced surface expression of all en-
dogenously encoded CD8 proteins (CD8 , CD8  , and
CD8 ), but not any transgene-encoded CD8 proteins
(CD8 , CD8  ). Because endogenously encoded and
transgene-encoded CD8  proteins are essentially identical,
these results demonstrate that CD8 protein internalization
cannot be the mechanism by which intrathymic MHC-I
signals reduce CD8 surface protein expression and con-
vert positively selected DP thymocytes into transitional
CD4 8lo cells.
Assessment of CD8 Protein Externalization as the Basis for
Reduced CD8 Surface Protein Expression on MHC-I–signaled
Thymocytes. Having excluded CD8 protein internaliza-
tion as the basis for reduced CD8 surface protein expres-
sion on MHC-I–signaled thymocytes, we next considered
whether CD8 protein externalization might be the expla-
nation. It has been proposed that TCR-signaled DP thy-
mocytes undergo a complex set of changes in coreceptor
surface protein expression that occur independently of,
and before, changes in coreceptor gene expression (9, 23).
In this proposal, TCR-signaled DP thymocytes initially
remove both CD4 and CD8 proteins from the cell surface
to phenotypically convert into CD4lo8lo thymocytes that
then phenotypically become CD4 8lo cells because CD4
proteins are more rapidly reexpressed on the cell sur-
face than CD8 proteins. Thus, transgenic CD8  pro-
teins might also be more rapidly reexpressed on the cell
surface than endogenous CD8  proteins, explaining why
CD4 8lo cells expressed low surface levels of endogenous
CD8  proteins but high surface levels of transgenic CD8 
proteins (Figs. 2–4). Consequently, we compared relative
reexpression rates of transgenic and endogenous CD8 sur-
face proteins on thymocytes after surface coreceptor pro-
teins had been stripped away by treatment with the extra-
cellular protease, pronase. We did this in two different
ways. We used allele-specific anti-CD8  mAbs to deter-
mine reexpression rates of endogenous CD8 .2 and trans-
genic CD8 .1 proteins on DP thymocytes expressing both
CD8  proteins (Fig. 5 A), and we used a pan-CD8  mAb
to determine reexpression rates of endogenous CD8 .2
and transgenic CD8 .1 proteins on DP thymocytes ex-
pressing only one or the other CD8  protein (Fig. 5 B). In
both experimental situations, CD4 proteins were reex-
pressed on the cell surface at a faster rate than CD8 pro-
teins and could be detected on the cell surface first (Fig. 5,
A and B), as originally described (23). However, endoge-
nous and transgenic CD8  proteins were reexpressed on
the cell surface at identical rates, regardless of how this ex-
periment was performed (Fig. 5, A and B). Consequently,
for differential reexpression rates of coreceptor proteins to
be the explanation for MHC-I–signaled CD4 8lo  thy-
mocytes, CD4 8lo thymocytes would have to be low for
expression of both endogenous and transgenic CD8  pro-
teins as their reexpression rates are identical. But, despite
identical reexpression rates, MHC-I–signaled CD4 8lo
thymocytes only exhibited low surface levels of endoge-
nously encoded CD8  proteins but exhibited high surface
levels of transgenically encoded CD8  proteins (Figs. 2–4).
Thus, the phenotypic appearance of MHC-I–signaled thy-
mocytes as CD4 8lo cells is not due to differential rates of
coreceptor protein externalization.
We conclude that the appearance of MHC-I–signaled
thymocytes as CD4 8lo cells is neither due to rapid inter-
nalization nor slow externalization of CD8 surface proteins.
Rather, the difference in expression of endogenous and
transgenic CD8  molecules on MHC-I–signaled CD4 8lo
thymocytes must reflect the impact of TCR signals on en-
dogenous CD8 regulatory elements that are not present in
the hCD2-based transgene and result in the selective
down-regulation of endogenous CD8 gene expression.
Initial Cessation of CD8 Gene Expression Does Not Imply
Lineage Commitment. If MHC-I signals down-regulate
CD8 gene expression in positively selected DP thymocytes
Figure 4. Effect of intrathy-
mic MHC-I signals on sur-
face expression of CD8  
homodimeric complexes. Thy-
mocytes were obtained from
MHC-IIo  CD8 o  mice that
expressed both endogenous
CD8 .2 and transgenic CD8 .1
molecules as CD8   complexes.
Thymocytes were surface stained
for TCR , CD4, CD8 , and ei-
ther CD8 .2 (endogenous CD8 ) or CD8 .1 (transgenic CD8 ) expression and analyzed by four color flow cytometry. Shown on whole thymus pop-
ulations are CD4 versus CD8  expression, CD4 versus CD8 .2 expression, and TCR  expression (left panels). CD4 versus CD8 .2 expression on gated
TCRhi thymocytes is shown and identifies CD8 .2lo cells (mostly CD4  cells, blue rectangular gate) and CD8  .2hi cells (mostly CD4  cells, red rectan-
gular gate). CD8 .1 surface expression was found to be similar on CD8 .2lo (blue line) and CD8 .2hi (red line) TCRhi thymocytes (right panel).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
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thereby causing them to become transitional CD4 8lo cells
before their terminal differentiation into CD8  T cells,
MHC-I–signaled CD4 8lo thymocyte populations should
contain two distinct subpopulations: one subpopulation
consisting of signaled (i.e., TCRhi) thymocytes that are
transcriptionally CD4 8 , and the other subpopulation
consisting of signaled TCRhi cells that are the immediate
progeny of CD4 8  cells that have just undergone core-
ceptor reversal and become transcriptionally CD4 8 .
To experimentally identify such subpopulations among
MHC-I–signaled CD4 8lo thymocytes, we subjected sorted
CD4 8lo thymocytes to the coreceptor reexpression assay
in which they were treated with extracellular pronase to re-
move preexisting CD4 and CD8 surface coreceptor pro-
teins and cultured overnight to allow surface reexpression
of the coreceptor molecules actively being transcribed (Fig.
6; reference 22). Note that we have previously docu-
mented that the coreceptor reexpression assay reveals the
coreceptor genes that individual thymocytes are actively
transcribing and the coreceptor mRNAs that they contain
(22, 24). Applying the coreceptor reexpression assay, we
found that CD4 8  and CD4 8  TCRhi subpopulations
were both present among electronically sorted CD4 8lo
thymocytes from MHC-IIo mice (Fig. 6, populations a and
c). Also unavoidably included in the CD4 8lo sorting gate
were unsignaled (i.e., TCRlo) DP thymocytes that reex-
pressed both CD4 and CD8 (Fig. 6, population b), and un-
signaled TCRlo DP thymocytes that were presumably in
the early stages of apoptosis and so reexpressed neither
CD4 nor CD8 (Fig. 6). Importantly, both of these latter
subpopulations were TCRlo, indicating that they had not
been signaled in vivo (Fig. 6). Thus, this experiment con-
firms that MHC-I–signaled TCRhi thymocytes that pheno-
typically appear as CD4 8lo cells actually consist of two
TCRhi subpopulations that, as revealed by the coreceptor
reexpression assay, are CD4 8  and CD4 8 .
Consequently, we asked if in vivo MHC-I–signaled
TCRhi CD4 8lo thymocytes that reexpressed only CD4
coreceptor proteins and therefore were CD4 8  for core-
ceptor gene expression still retained the potential to differ-
Figure 5. Reexpression rates of endogenous and transgenic coreceptor
proteins. (A) Thymocytes from MHC-IIo mice that carried the CD8  trans-
gene and expressed both endogenous CD8 .2 and transgenic CD8 .1 mol-
ecules were stripped of all surface coreceptor proteins by treatment with ex-
tracellular pronase. The stripped thymocytes were cultured in single cell
suspensions at 37 C for varying times, and assessed for reexpression of CD4,
CD8 .2, and CD8 .1 by staining with anti-CD4 and allele-specific anti-
CD8 mAbs. Displayed are histograms of CD4 versus CD8 .2 and CD4 ver-
sus CD8 .1, reexpression at different times after pronase stripping. Although
CD4 reexpression occurred more quickly than CD8 reexpression, the kinet-
ics of reexpression of endogenous CD8 .2 and transgenic CD8 .1 mole-
cules were identical. (B) Thymocytes were obtained from MHC-IIo mice
expressing only endogenous CD8 .2 molecules, and from MHC-IIo
CD8 o mice that contained the CD8  transgene and therefore expressed
only transgenic CD8 .1 molecules. Thymocytes were stripped of surface
coreceptor proteins by treatment with extracellular pronase, cultured in sin-
gle cell suspensions at 37 C for varying times, and assessed for reexpression of
CD4 and CD8  by staining with anti-CD4 and a pan anti-CD8 mAb that
recognizes both CD8 .1 and CD8 .2 isoforms. Line graphs show quantita-
tive reexpression of CD4 and CD8 surface proteins relative to their maxi-
mum reexpression at 24 h, which was set equal to 100%. The kinetics of
CD4 reexpression were identical on thymocytes from MHC-IIo and CD8 
transgenic MHC-IIo CD8 o mice, but are displayed only for the former.
Quantitation of surface reexpression versus time of CD4 (blue line), endoge-
nous CD8 .2 (red line), and transgenic CD8 .1 (green line) are displayed.T
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entiate into CD4 8  cells. To address this question, we
used MHC-IIo mice containing a reporter transgene (re-
ferred to as Line 30; reference 31) that is composed of
hCD2 cDNA under the control of CD4 enhancer and si-
lencer elements and therefore faithfully reports in vivo
CD4 transcription by surface expression of hCD2 reporter
protein. We obtained in vivo–signaled CD4 8lo  thy-
mocytes from such MHC-IIo Line 30 mice by electronic
cell sorting (Fig. 7, a and b), identified the subpopulation
that was transcriptionally CD4 8  in the coreceptor reex-
pression assay (Fig. 7, d), and purified cells that were
CD4 8  hCD2  by further electronic sorting (Fig. 7, c).
The purified cells were then placed into short-term cul-
tures with IL-7, a cytokine present in the normal thymus,
to maintain cell viability (24, 26). Unlike sorted CD4 8 
cells that remained DP in culture (Fig. 7, g and i), most
CD4 8  hCD2  cells underwent a dramatic change, termi-
nating CD4 gene transcription (as indicated by absent CD4
and absent hCD2 reexpression) and reinitiating CD8 gene
expression (as revealed by CD8 reexpression; Fig. 7, f and
h). Thus, most in vivo MHC-I–signaled CD4 8  thy-
mocytes underwent coreceptor reversal in vitro, converting
into CD4 8  cells. A minority of CD4 8  hCD2  cells did
not change coreceptor gene expression in culture (Fig. 7, f
and h).
We conclude that intrathymic MHC-I–signaled DP thy-
mocytes phenotypically convert into CD4 8lo cells because
they have transiently terminated CD8 gene expression to
become CD4 8  cells. We also conclude that many such
CD4 8  cells remain lineage uncommitted as they retain
the potential to reverse coreceptor gene expression and to
differentiate into CD4 8  cells.
Discussion
Most models of lineage commitment incorporate the
concept that lineage commitment occurs in DP thymocytes
and results in permanent silencing of the opposite corecep-
tor gene (9, 10). From this perspective the paradoxical ap-
pearance of MHC-I–signaled DP thymocytes as CD4 8lo
intermediates would be due to removal or redistribution of
CD8 surface proteins, and not due to down-regulation of
CD8 gene expression. However, this study documents that
removal or redistribution of CD8 surface proteins is not the
basis for conversion of MHC-I–signaled DP thymocytes
into CD4 8lo cells, but rather that it is due to down-regula-
tion of CD8 gene expression. This study also demonstrates
that MHC-I–signaled thymocytes that have down-regu-
lated CD8 gene expression to become CD4 8  cells still
retain the potential to differentiate into CD8  T cells.
Thus, initial cessation of CD8 gene expression does not
imply commitment to the CD4  T cell lineage, as it occurs
in MHC-I–signaled thymocytes during differentiation into
CD8  T cells.
That many MHC-I–signaled DP thymocytes phenotypi-
cally convert into CD4 8lo cells during differentiation into
CD8SP T cells was a surprising observation made indepen-
dently by two different laboratories (21, 22) that has since
been confirmed by others (18, 19, 23, 36). Importantly,
MHC-I–signaled CD4 8lo thymocytes are not dead-end
cells, but are cells on their way to differentiating into
CD8SP T cells (18, 21, 22). Nevertheless, the molecular
basis for this observation has been uncertain. Two explana-
tions have been proposed that can reconcile the appearance
of MHC-I–signaled CD4 8lo thymocytes with the concept
that lineage commitment occurs in DP thymocytes and re-
sults in permanent silencing of the opposite coreceptor
gene. The first explanation posits that MHC-I–specific
TCR interactions signal DP thymocytes to internalize
surface CD8 coreceptor proteins even as they induce DP
thymocytes to terminate CD4 gene expression (22). The
second explanation is more complex and posits that
MHC-I–specific TCR interactions signal DP thymocytes
to remove both CD4 and CD8 coreceptor proteins from
the cell surface that are then reexpressed at different rates,
with the effect that MHC-I–signaled DP thymocytes tran-
siently appear as CD4 8lo cells though they continue to ac-
tively express both coreceptor genes (9, 23). Both explana-
tions have now been excluded by this study.
This study used an hCD2-based CD8 .1 transgene that
is expressed on thymocytes at similar levels to that of en-
dogenous CD8 .2 proteins. Endogenous and transgenic
CD8  proteins are essentially identical, but the genes en-
coding them are controlled by entirely different regulatory
elements, as expression of endogenous CD8  genes is con-
trolled by endogenous CD8 promoter/enhancer elements
Figure 6. Analysis of MHC-I–
signaled (TCRhi) CD4 8lo tran-
sitional thymocytes by the
coreceptor reexpression assay.
Thymocytes obtained from
MHC-IIo  Line 30 mice were
electronically sorted to obtain
cells enriched in CD4 8lo transi-
tional thymocytes. Line 30 mice
contain a reporter transgene in
which surface expression of the hCD2 reporter protein reflects CD4 promoter activity (reference 31). The sorted thymocytes were pronase stripped, cul-
tured overnight in 37 C suspension cultures, and assessed by multicolor flow cytometry for expression of CD4, CD8 , and TCR . CD4 8lo transitional
thymocytes consist primarily of two TCRhi subpopulations as determined by the coreceptor reexpression assay: a CD4 8  subpopulation (a) and a
CD4 8  subpopulation (c). Sorted CD4 8lo thymocytes that either reexpressed both CD4 and CD8 (b), or neither CD4 nor CD8, were TCRlo and
therefore considered to have not been signaled in vivo. Note that previous analyses have documented that CD4 and CD8 protein reexpression in the
coreceptor reexpression assay parallels CD4 and CD8 mRNA expression as assessed by RT-PCR (references 24 and 26).T
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(37–42) whereas expression of the CD8  transgene is con-
trolled by heterologous hCD2 promoter/enhancer ele-
ments (29, 34). This study found that MHC-I–signaled
CD4 8lo thymocytes expressed low surface levels of endog-
enously encoded CD8  proteins but expressed high surface
levels of transgenically encoded CD8  proteins, an obser-
vation that is not consistent with a direct effect of MHC-I
signals on CD8  surface protein expression. Nevertheless,
to document that internalization of CD8 surface complexes
was not the mechanism by which MHC-I–signaled thy-
mocytes appeared in vivo as CD4 8lo cells, we evaluated
and excluded the possibility that MHC-I signals internal-
ized only specific subsets of CD8 surface protein com-
plexes, such as those containing only tailless CD8   pro-
teins, those consisting only of CD8    heterodimeric
complexes, or only of CD8   homodimeric complexes.
And to document that slow externalization of CD8 protein
complexes was not the mechanism by which MHC-I–sig-
naled thymocytes appeared in vivo as CD4 8lo cells, we
evaluated and excluded the possibility that transgenic
CD8  proteins, like CD4 proteins, might be reexpressed
on the cell surface at a faster rate than endogenous CD8 
proteins (23). Consequently, regardless of whether MHC-I
signals stimulate the removal and/or reexpression of surface
coreceptor proteins, this study demonstrates that such
events are not the mechanism by which MHC-I–signaled
thymocytes convert in vivo into CD4 8lo  thymocytes.
Rather, the appearance of MHC-I–signaled thymocytes as
CD4 8lo cells must result from transient down-regulation
of endogenous CD8 gene expression.
Supporting this conclusion, we found that in vivo
MHC-I–signaled CD4 8lo  thymocytes consisted of two
subpopulations of TCRhi cells with different patterns of
coreceptor gene expression: one subpopulation that had in-
deed down-regulated CD8 gene expression to become
CD4 8 , and the other subpopulation whose corecep-
tor  gene expression was CD4 8 . That the transitional
CD4 8lo population contained TCRhi thymocytes with a
coreceptor gene expression pattern of CD4 8  was con-
cordant with our conclusion that MHC-I–signaled thy-
mocytes phenotypically appeared as CD4 8lo cells because
of down-regulated CD8 gene expression. Indeed, this
study demonstrates that despite having ceased CD8 gene
expression, such CD4 8  cells could undergo coreceptor
reversal into CD4 8  cells in the presence of IL-7, a cyto-
kine that is present within the normal thymus (43). As a re-
sult, TCRhi cells that are transcriptionally CD4 8  and in
the process of differentiating into mature CD8  T cells are
also present within the transitional CD4 8lo thymocyte
population because they are the immediate progeny of cells
that were transcriptionally CD4 8   before undergoing
coreceptor reversal. Thus, cessation of CD8 gene expres-
sion in in vivo–signaled thymocytes does not necessarily
imply CD4 lineage commitment, as such cells may un-
dergo coreceptor reversal and differentiate into CD8  T
cells (25).
It seems to us that the present results cannot be easily
reconciled with the concept that lineage commitment oc-
curs in DP thymocytes and results in permanent silencing
of the opposite coreceptor gene. Cessation of coreceptor
Figure 7. MHC-I–signaled CD4 8lo  thymocytes that
have ceased CD8 gene expression retain the ability to differ-
entiate into CD8  T cells. Thymocytes from MHC-IIo
Line 30 mice (a) were electronically sorted to obtain cells
enriched in CD4 8lo transitional thymocytes (b), which
were then pronase stripped, cultured overnight, and as-
sessed by multicolor flow cytometry for reexpression of
CD4, CD8 , and the hCD2 reporter protein (d). To de-
termine if coreceptor gene expression was fixed, purified
hCD2  CD4 8  cells (c) and CD4 8  cells (e) were cul-
tured in IL-7 and assessed for coreceptor reexpression (f
and g). Cultured cells were also assessed for reexpression of
the hCD2 protein that serves as a reporter of CD4 pro-
moter activity (h and i). Most CD4 8lo transitional thy-
mocytes that had ceased CD8 gene expression and there-
fore were hCD2   CD4 8   at the beginning of IL-7
culture (c), underwent coreceptor reversal and converted
into hCD2  CD4 CD8  cells (f and h). Thymocytes that
had not been signaled in vivo and therefore expressed both
CD4 and CD8 coreceptor genes did not alter coreceptor
gene expression in culture and remained hCD2lo CD4 8 
(g and i).T
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gene expression was originally equated with commitment
to the opposite coreceptor lineage (6, 16). For example, the
original instructional model postulated that MHC-specific
TCR plus coreceptor engagements dictated which core-
ceptor gene was silenced, whereas stochastic models postu-
lated that the selection of which coreceptor gene to silence
occurred randomly. Updated versions of the original in-
struction model no longer equate cessation of coreceptor
gene expression with lineage commitment, but postulate
that the strength or duration of the TCR signal in DP thy-
mocytes commits the cell to one coreceptor lineage and
that lineage choice is revealed by its subsequent silencing of
the opposite coreceptor gene (11, 14, 15, 44). Importantly,
cessation of coreceptor gene expression is still considered to
reflect an individual cell’s “commitment” to the opposite
coreceptor lineage. In contrast, the present results are con-
sistent with the kinetic signaling perspective that interme-
diate CD4 8  thymocytes are lineage-uncommitted cells
in which lineage commitment then occurs. In the kinetic
signaling model, transient cessation of CD8 gene expres-
sion occurs during differentiation of MHC-I–signaled DP
thymocytes and results in cessation of CD8-dependent
MHC-I–specific signaling which, in turn, promotes core-
ceptor reversal and differentiation into CD8SP T cells (24,
25). However, not all MHC-I–signaled thymocytes go
through a stage where they appear as CD4 8lo cells. For
example, DP thymocytes that express TCR with low ap-
parent affinity for intrathymic MHC-I ligands appear to
differentiate directly into CD8SP T cells without ever ap-
pearing as CD4 8lo cells (36, 45). It is possible that such
MHC-I–signaled cells do transiently down-regulate CD8
gene expression as proposed by the kinetic signaling model,
but their TCR signals are of such short duration as a result
of low ligand affinity that these cells undergo coreceptor
reversal and reinitiate CD8 gene expression before surface
CD8 protein levels can detectably decline (25). Whether or
not signals transduced by low affinity MHC-I–specific
TCR in fact induce transient down-regulation of CD8
gene expression before undergoing lineage commitment
remains to be determined.
This study demonstrates that the appearance of MHC-I–
signaled CD4 8lo thymocytes is due to down-regulation of
CD8 gene expression rather than to effects on CD8 surface
proteins, but it is possible that MHC-I–specific TCR sig-
nals may affect CD8 mRNA stability as well as CD8 tran-
scription. Our present observation that MHC-I–specific
TCR signals cause DP thymocytes to discontinue expres-
sion of all endogenously encoded CD8 genes (CD8  and
CD8 ) without affecting expression of CD8 transgenes in-
dicates that TCR signals target regulatory elements present
within the endogenous CD8 gene locus that are absent
from the hCD2-based transgene. Indeed, in vitro observa-
tions from this laboratory have previously demonstrated
that antibody-mediated TCR engagement of purified DP
thymocytes selectively terminates endogenous CD8 gene
transcription and modestly destabilizes both CD4 and CD8
coreceptor mRNAs (46, 47). We think that similar events
are likely occurring in in vivo–signaled DP thymocytes.
Although our understanding of CD4 and CD8 gene
transcription is still far from complete, current knowledge
of how CD8 and CD4 genes are transcriptionally regu-
lated provides some clues as to how TCR signaling in DP
thymocytes might selectively result in transient cessation
of CD8 gene expression and conversion of signaled DP
thymocytes into CD4 8  cells. To oversimplify the situa-
tion in developing thymocytes, lineage-specific expression
of CD8 and CD4 coreceptor genes appears to be regu-
lated by fundamentally opposite mechanisms, as CD8
gene expression is specifically up-regulated by activation
of stage-specific CD8 enhancer elements (37–42) and
CD4 gene expression is specifically down-regulated by ac-
tivation of a CD4 silencer element (31, 48, 49). As a re-
sult, the “basal” or “default” state of coreceptor gene ex-
pression in developing thymocytes might be considered to
be CD4 8 , as this represents a transcriptional state in
which neither CD8 enhancer elements nor CD4 silencer
elements are activated. However, enhancer usage within
the CD8 gene locus is known to shift during differentia-
tion of immature DP thymocytes into mature CD8  T
cells, as “immature” CD8 enhancer elements drive CD8
gene expression at the immature DP thymocyte stage of
differentiation and “mature” CD8 enhancer elements
drive CD8 gene expression at the mature CD8  T cell
stage of differentiation. Thus, TCR signals can induce the
basal transcriptional state in DP thymocytes by simply ter-
minating activation of immature CD8 enhancer elements.
It is interesting to further speculate (26) that TCR signals
in developing thymocytes might block activation of all
lineage-specific regulatory elements (i.e., CD8 enhancer
and CD4 silencer elements) with the result that persistent
TCR signaling would maintain CD4 gene expression
“on” and CD8 gene expression “off” (i.e., CD4 8 ), re-
sulting in thymocyte differentiation into CD4  T cells as
proposed by the kinetic signaling model.
In conclusion, this study demonstrates that the appear-
ance of MHC-I–signaled thymocytes as CD4 8lo cells re-
sults from transient cessation of CD8 gene expression. In-
deed, this study demonstrates that initial cessation of CD8
gene expression does not imply commitment to the CD4 
T cell lineage, as many in vivo MHC-I–signaled CD4 8 
cells are able to undergo coreceptor reversal and differenti-
ate into CD8  T cells. Thus, these observations support the
kinetic signaling model and challenge the concept that lin-
eage commitment occurs in DP thymocytes and results in
permanent silencing of the opposite coreceptor gene.
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